Status:
UNKNOWN
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
Lead Sponsor:
Beijing Tongren Hospital
Collaborating Sponsors:
The First Affiliated Hospital of Zhengzhou University
West China Hospital
Conditions:
Lung Neoplasms
Eligibility:
All Genders
30-80 years
Brief Summary
Lung cancer is one of the most common malignant tumors in the world and with the highest incidence in China. Surgery is the most effective therapeutic method for primary lung cancer. Accurate predicti...
Detailed Description
1. Newly diagnosed and pre-therapeutic patients with primary lung cancer 2. Study sample: the optimal study sample is expected to be \>50 cases 3. Inclusion criteria: age 30-80 years old; newly diagno...
Eligibility Criteria
Inclusion
- Inclusion criteria: age 30-80 years old; newly diagnosis of primary lung cancer with radiological or pathological evidence; SPECT/CT scan was performed before surgery; written and informed consent with signature before the study.
- Exclusion criteria: with other tumor in addition to primary lung caner; receive surgery prior to SPECT/CT scan; failed to complete preoperative and postoperative pulmonary function tests; failed to perform scans; pregnancy, lactation, and impaired renal or liver function; poorly controlled diabetes; poor compliance; contrary to the standard operating procedures; not suitable for clinical trials (for example with mental illness);
Exclusion
Key Trial Info
Start Date :
September 30 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03357094
Start Date
September 30 2017
End Date
November 1 2019
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongren Hospital
Beijing, Beijing Municipality, China